Abstract
This study examined the possible effects of a novel mixture of fatty acids, SR-3 (a specific ratio of a-linolenic acids), on brain biochemistry and on learning deficits induced by injection of an agent that induces experimental allergic encephalomyelitis. Treatment with SR-3 caused a decrease in myelin and changes in the fatty acid profile of brain synaptosomes, and a learning deficit. Eighteen days of treatment with SR-3 reversed the biochemical and learning deficit significantly, but did not restore them to normal levels. We propose that, most probably, the main action of SR-3 is the modulation of the cholesterol level, which in turn causes the modulation of the fatty acid profile and enhances learning by allowing improved neuronal communication.
| Original language | English |
|---|---|
| Pages (from-to) | 23-29 |
| Number of pages | 7 |
| Journal | European Journal of Pharmacology |
| Volume | 328 |
| Issue number | 1 |
| DOIs | |
| State | Published - Sep 1997 |
| Externally published | Yes |
Keywords
- Experimental allergic encephalomyelitis
- Fatty acid
- Linolenic acid
- Multiple sclerosis
- α-Linolenic acid
ASJC Scopus subject areas
- Pharmacology